Skip to main content
. 2015 Mar 27;7(3):289–303. doi: 10.4254/wjh.v7.i3.289

Table 3.

Clinical associations with hepatitis B virus genotypes

A B C D E F
Progression to chronicity +++ ++ +++ ++
Histological inflammation ++ ++ +++ +++ +/-
Histological fibrosis + + ++ ++ +/-
Association with advanced liver disease + ++ +++ ++ +/-
Association with HCC + (subgeno A1) + ++ ++ ++ (subgeno F2)
Early HBeAg seroconversion ++ +++ + +++ +++
Sustained remission after HBeAg Seroconversion +++ +++ ++ ++ ++
HBsAg clearance +++ ++ + ++
Response to IFN Tx +++ ++ + +/- + +++
Association with PreCore mutations - ++ + +++ ++ +++ (F1 but not F2)
Association with BCP mutation ++ ++ ++

+/-: Possible association; - : No association; +: Slight association; ++: Moderate association; +++: Strong association. HBeAg: Hepatitis B e antigen; BCP; Basal core promotor; HCC: Hepatocellular carcinoma; IFN: Interferon.